Trilogy Metals Inc. — Form 10-Q summary
Reporting period: Quarter and nine months ended August 31, 2026. Amounts are in U.S. dollars unless noted. Trilogy is an exploration and development company with a 50% interest in Ambler Metals LLC, which holds the Arctic and Bornite projects in Alaska. Neither the company nor its projects are producing; the filing reports no revenue.
Financial results and position
- Quarter: Net income was $0.2 million, compared with a $1.7 million net loss in the prior-year quarter. The result included an $11.6 million non-cash gain from remeasuring the Department of War (DOW) derivative liability, partly offset by a $9.6 million share of Ambler Metals’ loss and $2.1 million of company expenses.
- Nine months: Net loss was $13.2 million, versus $7.5 million in the comparable 2025 period. The $13.2 million share of Ambler Metals’ loss and $4.4 million of stock-based compensation were significant items; a $7.8 million derivative fair-value gain partly offset them.
- Revenue and margins: No revenue is reported, so operating margins are not meaningful.
- Cash flow: For the nine months, operating activities used $4.9 million, investing activities used $17.0 million (the contribution to Ambler Metals), and financing activities provided $1.4 million. Cash declined from $51.6 million at November 30, 2025 to $31.2 million at August 31, 2026.
- Liquidity: Current assets were $31.6 million and current liabilities were $23.9 million, including the $23.0 million derivative liability. Management reported adjusted working capital of $30.3 million after excluding that liability, which is settled through share and warrant issuance. Management said cash on hand was sufficient for the next 12 months, including the remaining $1.1 million 2026 corporate budget.
- Debt and obligations: The balance sheet shows no conventional borrowings. Lease liabilities totaled $81,000; the derivative liability was $23.0 million at quarter-end and was extinguished after quarter-end. Total liabilities were $23.9 million.
- Investment and equity: The Ambler Metals investment was carried at $109.0 million, up from $105.3 million at November 30, 2025, after a $17.0 million contribution and $13.2 million equity-method loss. Shareholders’ equity was $116.8 million. Shares outstanding were 172.9 million at quarter-end and 181.4 million as of October 2, 2026.
Material changes and significant events
- Ambler Metals’ exploration and project activity increased: Trilogy’s share of its loss rose to $9.6 million for the quarter and $13.2 million for the nine months, from $0.9 million and $2.2 million, respectively, in the prior-year periods. Management attributed the increase primarily to planned exploration activity and higher personnel costs.
- On September 11, 2026, after quarter-end, Trilogy completed a strategic investment by the DOW. Trilogy issued 8,215,570 units at $2.17 each for approximately $17.8 million gross proceeds. Each unit included one common share and three-quarters of a 10-year warrant; the warrants cover up to 6,161,678 shares at $0.01 per share, subject to specified project-use or change-of-control triggers.
- The proceeds are designated for a further capital contribution to Ambler Metals, matched by South32, and are not available for Trilogy’s general corporate needs. Trilogy’s 50% joint-venture interest is unchanged. The DOW also received board nomination and observer rights. Closing extinguished the derivative liability and generated a non-cash gain of approximately $3.9 million.
Outlook, risks and other matters
- No formal production, revenue or earnings guidance is provided. Management described the 2026 summer program as including drilling and technical work at Arctic, site-readiness work at Bornite, and regional exploration. The Arctic Project entered the federal FAST-41 permitting program; permitting, infrastructure development and project timelines remain uncertain.
- Trilogy’s 2026 corporate expenditure budget is $5.0 million. Its share of Ambler Metals’ 2026 budget is $17.5 million, of which $17.0 million had been funded by August 31. Management stated that additional funding may be needed beyond the next 12 months; potential sources include equity, debt, option exercises or the ATM program.
- Key risks include permitting and construction of the Ambler Access Project, project financing and development uncertainty, commodity and energy-price volatility, inflation, and possible future dilution. The DOW transaction adds covenant, governance, regulatory and geopolitical considerations; the filing describes restrictions on certain transactions and borrowing, including borrowing above $1 billion without DOW approval through the specified period.
- Fair value of the quarter-end derivative depended on Level 3 assumptions, including the estimated likelihood of Ambler Access Project completion. A 10% change in share price was estimated to affect the derivative gain or loss by about $4.1 million. The liability was subsequently extinguished.
- Management reported effective disclosure controls as of August 31, 2026, and no material change in internal control over financial reporting during the quarter. The company reported no material current, pending or threatened litigation of which it was aware.
Important facts for investors to verify
- Confirm the post-quarter DOW transaction’s final share count, restricted use and timing of the required contribution to Ambler Metals, and the conditions governing warrant exercise and potential dilution.
- Track permitting progress, FAST-41 milestones and the status, approvals and funding of the Ambler Access Project, which is central to project development and DOW warrant conditions.
- Assess Ambler Metals’ spending against its budget, remaining cash needs and Trilogy’s ability to fund its share, particularly given the $31.2 million quarter-end cash balance and reported 12-month liquidity outlook.
- Review future changes in Trilogy’s share of Ambler Metals’ losses and the carrying value and impairment assessment of its $109.0 million investment.
- Consider that quarterly and year-to-date earnings were materially affected by non-cash derivative remeasurement and stock-based compensation, rather than operating revenue.